Center Update
Casey Ostheimer knows how to nurture
Explore the academic adventures of undergraduate research assistant Casey Ostheimer, who worked with SCRMC and SMPH faculty member Owen Tamplin.
September 19, 2023
Computational tool helps uncover gene networks of cell fate
New research from the Wisconsin Institute for Discovery (WID) and SCRMC member Sushmita Roy, is providing key insights that will aid researchers in constructing a more precise view of what drives cellular identity.
August 10, 2023
New research expands understanding of impact of rapamycin on fragile X syndrome
A new study led by Waisman investigator and SCRMC member Xinyu Zhao, highlights the role elevated levels of the protein MAP1B and ASD play in fragile X syndrome (FXS) symptoms and identifies a potential treatment using the FDA-approved drug rapamycin. SCRMC members and Waisman investigators Andre Sousa and Qiang Chang also contributed to the study.
July 6, 2023
SCRMC director and collaborators receive Research Forward Award
Stem Cell and Regenerative Medicine Director, Tim Kamp and a team of collaborators will receive one of sixteen Research Forward grants to study new avenues to treat heart failure using an engineered enzyme and human pluripotent stem cells.
May 31, 2023
Congratulations to the Summer Undergraduate Research Fellowship (SURF) Award Winners!
These talented undergraduate students will be paired with mentors for more than 10-weeks of collaborative research.
May 17, 2023
2023 SCRMC Research Training Award Winners Announced
We invite you to meet the winners of the 2023 SCRMC Research Training Awards Program, which provides unique, interdisciplinary training for four future leaders in stem cell and regenerative medicine research. Additionally, this program will foster interdisciplinary collaborations among campus investigators.
April 18, 2023
Two SCRMC members receive the 2023-2024 Vilas Associates Award
Stem Cell & Regenerative Medicine members Feyza Engin and Ahmed Mahmoud have received the 2023-2024 University of Wisconsin-Madison Vilas Associates Award. This honor recognizes new and on-going research of the highest quality and significance.
April 17, 2023
SCRMC researchers identify cell type that could be key to preventing marrow transplant complication
New research from the University of Wisconsin–Madison is helping to change that by identifying the cell population that causes GVHD, a target that may make bone marrow transplants safer and more effective.
March 24, 2023
New nanocapsules deliver therapy brain-wide, edit Alzheimer’s gene in mice
Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier — the blood-brain barrier. Now, researchers at the University of Wisconsin–Madison have developed a way to move therapies across the brain’s protective membrane to deliver brain-wide therapy with a range of biological medications and treatments.
February 1, 2023
Lab-grown retinal eye cells make successful connections, open door for clinical trials to treat blindness
A new study suggests that retinal cells grown from stem cells may be ready for trials in humans with degenerative eye disorders.
The organized clusters of cells, or organoids, used in the study were developed in the lab of David Gamm, a SCRMC member, UW–Madison ophthalmology professor, and director of the McPherson Eye Research Institute. While these organoids were developed nearly a decade ago, this is the first time that Gamm and his lab have shown that the organoids have the capacity to communicate across synapses, tiny gaps between cells. This is an important development, which indicates that these organoids can replace diseased cells and carry sensory information to the brain.
January 24, 2023
Improved understanding of early spinal cord development paves the way for new treatments
Researchers at the University of Wisconsin–Madison are developing the means to turn stem cells into a wide range of specific types of spinal cord neurons and cells in the hindbrain — the critical nexus between the spinal cord and the brain — paving the way for improved prevention and treatment of spinal cord disease.
October 18, 2022
New Department of Defense Grant to Study Fragile X Syndrome in Human Cells
A new study will characterize human stem cell models of fragile X syndrome (FXS) to better understand the mechanisms behind FXS symptoms and how those may inform the search for effective therapies. The study, which will be supported by a three-million-dollar U.S. Department of Defense (DOD) grant, will be led by Xinyu Zhao professor of neuroscience, and Anita Bhattacharyya, assistant professor of cell and regenerative biology. Both are also Waisman Center investigators and Stem Cell and Regenerative Medicine members.
October 4, 2022
SURF program prepares students to ride the waves of research
The Stem Cell and Regenerative Medicine Center labs welcomed new members this summer, as five talented undergraduate students joined mentors for more than 10-weeks of collaborative research. This unique experience is a part of the Summer Undergraduate Research Fellowship (SURF), which supports motivated University of Wisconsin–Madison undergraduate students as they pursue research in the stem cell sciences.
September 28, 2022
Upcoming Events
Keerthana Shankar (Saha Lab) presents, “Manufacturing virus-free CRISPR CAR Natural Killer Cells for GD2+ solid tumors.”
Dr. Jeffrey Dilworth, Professor-CRB, presents, “Epigenetic control of muscle stem cell fate during regeneration.”
